Circulating cellular players in vascular calcification

Current Pharmaceutical Design

Volumn 20, Issue 37, 2014, Pages 5889-5896

  Albiero, Mattia ^a   Avogaro, Angelo ^a,b   Fadini, Gian Paolo ^a,b  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Atherosclerosis; Calcification; Cardiovascular disease; Diabetes; Endothelium; Stem cells

Indexed keywords

CALCIUM PHOSPHATE; HYDROXYAPATITE;

ARTERY WALL; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE MARROW CELL; CIRCULATING MYELOID CALCIFYING CELL; ENCHONDRAL OSSIFICATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; OSTEOPROGENITOR CELL; VASCULAR SMOOTH MUSCLE; ANIMAL; METABOLISM; PATHOLOGY;

ANIMALS; BONE MARROW CELLS; HUMANS; VASCULAR CALCIFICATION;

EID: 84911484320     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140212193848     Document Type: Article

References (85)

1. Qiao J-H, Mertens RB, Fishbein MC, Geller SA. Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: Morphologic evidence of enchondral ossification. Hum Pathol 2003; 34(4): 402-7.
2. Aikawa M, Libby P. The vulnerable atherosclerotic plaque: Pathogenesis and therapeutic approach. Cardiovasc Pathol 2004; 13(3): 125-38.
3. Hunt JL, Fairman R, Mitchell ME, et al. Bone formation in carotid plaques: A clinicopathological study. Stroke 2002; 33(5): 1214-9.
4. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. Medial localization of mineralization-regulating proteins in association with mönckeberg's sclerosis: Evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100(21): 2168-76.
5. Hyder JA, Allison MA, Wong N, et al. Association of coronary artery and aortic calcium with lumbar bone density: The MESA abdominal aortic calcium study. Am J Epidemiol 2009; 169(2): 186-94.
6. Price PA, June HH, Buckley JR, Williamson MK. SB 242784, a selective inhibitor of the osteoclastic V-H+atpase, inhibits arterial calcification in the rat. Circ Res 2002; 91(6): 547-52.
7. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 2002; 277(6): 3926-34.
8. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87(11): 1055-62.
9. Geng Y-J, Libby P. Progression of atheroma: A struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002; 22(9): 1370-80.
10. Reynolds JL, Skepper JN, McNair R, et al. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 2005; 16(10): 2920-30.
11. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386(6620): 78-81.
12. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005; 97(2): 105-14.
13. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108(1): 17-29.
14. Galvin KM, Donovan MJ, Lynch CA, et al. A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 2000; 24(2): 171-4.
15. Dorai H, Vukicevic S, Sampath TK. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 2000; 184(1): 37-45.
16. Giachelli CM, Steitz S. Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biol 2000; 19(7): 615-22.
17. Speer MY, McKee MD, Guldberg RE, et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix gla protein-deficient mice: Evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002; 196(8): 1047-55.
18. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC. Progression of aortic calcification is associated with metacarpal bone loss during menopause: A population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000; 20(8): 1926-31.
19. Demer LL, Tintut Y. Mineral exploration: Search for the mechanism of vascular calcification and beyond: The 2003 jeffrey M. Hoeg award lecture. Arterioscler Thromb Vasc Biol 2003; 23(10): 1739-43.
20. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004; 95(11): 1046-57.
21. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteo-protegerin: Paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002; 22(4): 549-53.
22. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappab ligand and osteoprotegerin in bone cell biology. J Mol Med (Berl) 2001; 79(5-6): 243-53.
23. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12(9): 1260-8.
24. Whyte MP, Obrecht SE, Finnegan PM, et al. Osteoprotegerin deficiency and juvenile paget's disease. N Engl J Med 2002; 347(3): 175-84.
25. Deuell KA, Callegari A, Giachelli CM, Rosenfeld ME, Scatena M. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: Dependence on IL-6 and tnf-α. J Vasc Res 2012; 49(6): 510-21.
26. Callegari A, Coons M, Ricks JL, et al. Bone marrow-or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. Arterioscler Thromb Vasc Biol 2013, Aug 29.
27. Fadini GP, Albiero M, Menegazzo L, et al. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res 2011; 108(9): 1112-21.
28. Speer MY, Yang HY, Brabb T, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009; 104(6): 733-41.
29. Naik V, Leaf EM, Hu JH, et al. Sources of cells that contribute to atherosclerotic intimal calcification: An in vivo genetic fate mapping study. Cardiovasc Res 2012, Apr 14.
30. Doehring LC, Heeger C, Aherrahrou Z, et al. Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocytelike cells in atherosclerotic intimal calcification. Am J Pathol 2010; 177(1): 473-80.
31. Hajdu Z, Romeo SJ, Fleming PA, Markwald RR, Visconti RP, Drake CJ. Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic process. J Mol Cell Cardiol 2011; 51(6): 955-65.
32. Tanaka K, Sata M, Fukuda D, et al. Age-associated aortic stenosis in apolipoprotein e-deficient mice. J Am Coll Cardiol 2005; 46(1): 134-41.
33. Scheven BAA, Visser JWM, Nijweide PJ. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 1986; 321(6065): 79-81.
34. Suda RK, Billings PC, Egan KP, et al. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 2009; 27(9): 2209-19.
35. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996; 137(9): 4058-60.
36. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 2004; 36(4): 585-97.
37. Fernandez M, Simon V, Herrera G, Cao C, DelFavero H, Minguell JJ. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplantation 1997; 20(4): 265-71.
38. Otsuru S, Rasini V, Bussolari R, Hofmann TJ, Dominici M, Hor-witz EM. Cytokine-induced osteopoietic differentiation of transplanted marrow cells. Blood 2011; 118(8): 2358-61.
39. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol 2001; 153(5): 1133-40.
40. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000; 2(6): 477-88.
41. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 2007; 354(2): 453-8.
42. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are re cruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008; 26(1): 223-34.
43. Alm JJ, Koivu HMA, Heino TJ, Hentunen TA, Laitinen S, Aro HT. Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res 2010; 28(12): 1634-42.
44. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S. Circulating osteoblast-lineage cells in humans. N Engl J Med 2005; 352(19): 1959-66.
45. Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: The role of reparatory mechanisms. Diabetes Care 2011; 34 Suppl 2: S285-90.
46. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, Feb 14; 275(5302): 964-7.
47. Fadini GP, Rattazzi M, Matsumoto T, Asahara T, Khosla S. Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation 2012; 125(22): 2772-81.
48. Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med 2012; 2(7): a006692.
49. Menegazzo L, Albiero M, Avogaro A, Fadini GP. Endothelial progenitor cells in diabetes mellitus. Biofactors 2012; 38(3): 194-202.
50. Albiero M, Menegazzo L, Fadini GP. Circulating smooth muscle progenitors and atherosclerosis. Trends Cardiovasc Med 2010; 20(4): 133-40.
51. Fadini GP, Tjwa M. A role for tgf-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis 2010; 211(1): 32-5.
52. Imamura H, Ohta T, Tsunetoshi K, et al. Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by tansforming growth factor-beta1. Atherosclerosis 2010; 211(1): 114-21.
53. Chen JL, Hunt P, McElvain M, Black T, Kaufman S, Choi ES. Osteoblast precursor cells are found in CD34+ cells from human bone marrow. Stem Cells 1997; 15(5): 368-77.
54. Gössl M, Mödder UI, Atkinson EJ, Lerman A, Khosla S. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 2008; 52(16): 1314-25.
55. Gössl M, Mödder UI, Gulati R, et al. Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J 2010; 31(23): 2909-14.
56. Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal stem cells derived from cd133-positive cells in mobilized peripheral blood and cord blood: Proliferation, oct4 expression, and plasticity. Stem Cells 2005; 23(8): 1105-12.
57. Matsumoto T, Mifune Y, Kawamoto A, et al. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 2008; 215(1): 234-42.
58. Matsumoto T, Kawamoto A, Kuroda R, et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood cd34-positive cells for functional bone healing. Am J Pathol 2006; 169(4): 1440-57.
59. Mifune Y, Matsumoto T, Kawamoto A, et al. Local delivery of granulocyte colony stimulating factor-mobilized cd34-positive progenitor cells using bioscaffold for modality of unhealing bone fracture. Stem Cells 2008; 26(6): 1395-405.
60. Kuroda R, Matsumoto T, Miwa M, et al. Local transplantation of g-csf-mobilized CD34(+) cells in a patient with tibial nonunion: A case report. Cell Transplant 2011; 20(9): 1491-6.
61. Fukui T, Matsumoto T, Mifune Y, et al. Local transplantation of granulocyte colony-stimulating factor-mobilized human peripheral blood mononuclear cells for unhealing bone fractures. Cell Transplant 2012; 21(4): 707-21.
62. Flammer AJ, Gössl M, Li J, et al. Patients with an hba1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers. J Clin Endocrinol Metab 2012; 97(12): 4761-8.
63. Flammer AJ, Gössl M, Widmer RJ, et al. Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis. Eur Heart J 2012; 33(23): 2963-9.
64. Gössl M, Khosla S, Zhang X, et al. Role of circulating osteogenic progenitor cells in calcific aortic stenosis. J Am Coll Cardiol 2012; 60(19): 1945-53.
65. Fadini GP, Albiero M, Menegazzo L, et al. Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. Exp Diabetes Res 2012; 2012: 921685.
66. Pirro M, Schillaci G, Mannarino MR, et al. Circulating immature osteoprogenitor cells and arterial stiffening in postmenopausal osteoporosis. Nutr Metab Cardiovasc Dis 2011; 21(9): 636-42.
67. Peris P, Atkinson EJ, Gössl M, et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. Mayo Clin Proc 2013; 88(1): 46-55.
68. Liu L, Liu Z-Z, Chen H, Zhang G-J, Kong Y-H, Kang X-X. Oxidized low-density lipoprotein and β-glycerophosphate synergisti-cally induce endothelial progenitor cell ossification. Acta Pharmacol Sin 2011; 32(12): 1491-7.
69. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5(12): 953-64.
70. Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MPJ, Donners MMPC. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 2013, Sep 8.
71. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012; 110(4): 624-37.
72. Udagawa N, Takahashi N, Akatsu T, et al. Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci 1990; 87(18): 7260-4.
73. Quinn JM, McGee JO, Athanasou NA. Cellular and hormonal factors influencing monocyte differentiation to osteoclastic bone-resorbing cells. Endocrinology 1994; 134(6): 2416-23.
74. Nagareddy PR, Murphy AJ, Stirzaker RA, et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 2013; 17(5): 695-708.
75. Albiero M, Rattazzi M, Menegazzo L, et al. Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression. Basic Res Cardiol 2013; 108(4): 368.
76. Mishima T, Iwabuchi K, Fujii S, et al. Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in apoe-/-mice. Int J Mol Med 2008; 21(2): 181-7.
77. Menegazzo L, Albiero M, Millioni R, et al. Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression. FASEB J 2013, Jul 30.
78. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, Iruela-Arispe ML. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloprote-inase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 2001; 98(22): 12485-90.
79. Collett GDM, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 2005; 96(9): 930-8.
80. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture. Arteriosclerosis, Thrombosis, and Vascular Biology 2005; 25(10): 2054-61.
81. Ehara S, Kobayashi Y, Yoshiyama M, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: An intravascular ultrasound study. Circulation 2004; 110(22): 3424-9.
82. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: Observations from a registry of 25, 253 patients. J Am Coll Cardiol 2007; 49(18): 1860-70.
83. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 2001; 103(8): 1051-6.
84. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hema-tol 2010; 38(7): 548-56.
85. Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature 2012; 487(7407): 325-9.